Table 2.
Baseline characteristics (ITT population).
| Oral rabeprazole group (n = 54) | IV omeprazole group (n = 52) | P value | |
|---|---|---|---|
| Ulcer size (mm) | 13.7 ± 12.2 | 10.5 ± 11.1 | 0.173 |
| Ulcer type | 0.415 | ||
| GU | 30 | 27 | |
| DU | 21 | 20 | |
| GU and DU | 3 | 5 | |
| Helicobacter pylori | 0.653 | ||
| Positive | 22 | 19 | |
| Negative | 24 | 28 | |
| Unknown | 8 | 5 | |
| Stigmata of hemorrhage | 0.912 | ||
| Active arterial spurting | 6 | 4 | |
| Oozing | 15 | 14 | |
| Nonbleeding visible vessel | 21 | 23 | |
| Adherent clot | 12 | 11 | |
| Endoscopic treatment | 0.254 | ||
| Epi + hemoclip | 36 | 29 | |
| Epi only | 7 | 8 | |
| Hemoclip only | 6 | 5 | |
| Epi + APC | 2 | 5 | |
| Epi + mono | 0 | 2 | |
| Epi + hemoclip + APC | 2 | 0 | |
| Epi + hemoclip + mono | 1 | 0 | |
| EBL | 0 | 2 | |
| APC | 0 | 1 |
ITT: intention-to-treat; IV: intravenous; GU: gastric ulcer; DU: duodenal ulcer; Epi: epinephrine injection (1 : 10,000 dilution in saline); APC: argon plasma coagulation; mono: monopolar coagulation; EBL: endoscopic band ligation.